Vaccines Alone Cannot Slow the Evolution of SARS-CoV-2
Vaccines · 16.04.2023 · 11 (4) · 853
DOI: 10.3390/vaccines11040853 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vaccines, online erschienen am 16.04.2023. Verfasst von Debra Van Egeren und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Weill Cornell Medicine, New York, NY 10021, USA. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The rapid emergence of immune-evading viral variants of SARS-CoV-2 calls into question the practicality of a vaccine-only public-health strategy for managing the ongoing COVID-19 pandemic. It has been suggested that widespread vaccination is necessary to prevent the emergence of future immune-evading mutants. Here, we examined that proposition using stochastic computational models of viral transmission and mutation. Specifically, we looked at the likelihood of emergence of immune escape variants requiring multiple mutations and the impact of vaccination on this process. Our results suggest that the transmission rate of intermediate SARS-CoV-2 mutants will impact the rate at which novel immune-evading variants appear. While vaccination can lower the rate at which new variants appear, other interventions that reduce transmission can also have the same effect. Crucially, relying solely on widespread and repeated vaccination (vaccinating the entire population multiple times a year) is not sufficient to prevent the emergence of novel immune-evading strains, if transmission rates remain high within the population. Thus, vaccines alone are incapable of slowing the pace of evolution of immune evasion, and vaccinal protection against severe and fatal outcomes for COVID-19 patients is therefore not assured.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Weill Cornell Medicine, New York, NY 10021, USA.
- New York Genome Center, New York, NY 10013, USA.
- Fractal Therapeutics, Lexington, MA 02420, USA.
- Department of Biostatistics, Boston University School of Public Health, Boston, MA 02118, USA.
- Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA.
- Department of Medicine, Boston University School of Medicine, Boston, MA 02118, USA.
ORCID-Profile: Debra Van Egeren, Madison Stoddard, Laura F White, Diane Joseph-McCarthy
Zitieren
APA
Van Egeren, D., Stoddard, M., White, L. F., Hochberg, N. S., Rogers, M. S., Zetter, B., Joseph-McCarthy, D., & Chakravarty, A. (2023). Vaccines Alone Cannot Slow the Evolution of SARS-CoV-2. Vaccines, 11(4), 853. https://doi.org/10.3390/vaccines11040853
Vancouver
Van Egeren D, Stoddard M, White LF, Hochberg NS, Rogers MS, Zetter B, et al. Vaccines Alone Cannot Slow the Evolution of SARS-CoV-2. Vaccines. 2023;11(4):853. doi:10.3390/vaccines11040853
BibTeX
@article{VanEgeren2023,
author = {Van Egeren, Debra and Stoddard, Madison and White, Laura F and Hochberg, Natasha S and Rogers, Michael S and Zetter, Bruce and Joseph-McCarthy, Diane and Chakravarty, Arijit},
title = {Vaccines Alone Cannot Slow the Evolution of SARS-CoV-2},
journal = {Vaccines},
year = {2023},
volume = {11},
number = {4},
pages = {853},
doi = {10.3390/vaccines11040853}
}
EUVIMED